SELECT MEDICAL HOLDINGS CORP

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $115.4m
$177.2m +53.52%
$137.8m -22.21%
$148.4m +7.70%
$259.0m +74.47%
$402.2m +55.30%
$159.0m -60.47%
$243.5m +53.14%
$214.0m -12.10%
$146.2m -31.69%
Net Income (Loss) Available to Common Stockholders, Basic $111.9m
$171.4m +53.21%
$133.3m -22.25%
$143.5m +7.63%
$250.1m +74.34%
$388.8m +55.45%
$153.4m -60.55%
$234.7m +53.03%
$296.7m +26.41%
$214.5m -27.69%
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $125.3m $220.6m $176.9m $201.0m $344.6m $499.9m $198.0m $299.7m $296.7m $214.5m
Net Income (Loss) Attributable to Noncontrolling Interest $9.9m $43.5m $39.1m $52.6m $85.6m $97.7m $39.0m $56.2m $82.7m $68.3m
Depreciation and amortization $145.3m $160.0m $201.7m $212.6m $205.7m $202.6m $205.8m $208.7m $203.9m $140.3m $143.2m
Depreciation $129.0m $142.6m $171.7m $182.9m $178.0m $173.2m $174.8m $177.1m $141.1m $138.5m $143.2m
Amortization of Debt Issuance Costs and Discounts $15.7m $11.1m $13.1m $11.6m $2.2m $2.2m $2.3m $2.6m $3.0m $3.1m
Amortization of Intangible Assets $29.6m $27.6m $29.5m $31.0m $31.7m $1.6m $1.6m
Depreciation Amortization Depletion $205.8m $208.7m $203.9m $140.3m $143.2m
Deferred Income Tax Expense (Benefit) ($12.6m) ($72.3m) $7.2m ($7.4m) ($14.7m) $5.1m $7.5m ($16.1m) ($30.9m) $30.7m $42.6m
Deferred Tax $7.5m ($16.1m) ($32.4m) $30.7m $42.6m
Share-based Payment Arrangement, Noncash Expense $17.4m $19.3m $23.3m $26.5m $27.2m $30.9m $37.8m $43.8m $100.7m $16.7m $17.4m
Share-based Payment Arrangement, Expense $17.4m $19.3m $23.3m $26.5m $27.2m $30.9m $37.8m $43.8m $99.2m $16.7m $17.4m
Equity Method Investment, Other than Temporary Impairment $5.3m $0 $0
Income (Loss) from Equity Method Investments $19.9m $21.1m $21.9m $25.0m $29.4m $44.4m $26.4m $40.8m $60.2m $54.5m
Earnings (Loss)es From Equity Investments ($26.4m) ($40.8m) ($60.2m) ($54.5m) ($54.0m)
Changes in operating assets and liabilities:
Change In Working Capital ($159.5m) $59.5m ($55.1m) ($59.7m) ($16.3m)
Increase (Decrease) in Accounts Receivable $39.3m $197.2m ($54.6m) $58.0m $116.6m ($23.1m) $52.2m ($1.2m) $95.8m $45.2m ($42.5m)
Change In Receivables ($52.2m) $1.2m ($95.8m) ($45.2m) ($42.5m)
Changes In Account Receivables ($52.2m) $1.2m ($95.8m) ($45.2m) ($42.5m)
Increase (Decrease) in Accounts Payable ($15.5m) $3.9m ($1.8m) $5.7m $27.3m $53.4m ($48.0m) ($6.4m) ($16.8m) ($854k) $6.9m
Change In Payables And Accrued Expense ($35.2m) $77.7m $9.7m ($6.1m) $6.9m
Change In Accrued Expense $12.9m $84.1m $26.5m ($5.2m) $23.1m
Change In Other Current Assets $11.6m ($19.3m) $31.0m ($8.4m) ($3.8m)
Other Operating Income (Expense), Net $90.0m $144.0m $28.8m $1.8m $3.4m $1.6m
Net Cash Provided by (Used in) Operating Activities $346.6m
$238.1m -31.30%
$494.2m +107.53%
$445.2m -9.92%
$1.0b +130.93%
$401.2m -60.97%
$284.8m -29.01%
$582.1m +104.36%
$517.9m -11.03%
$346.5m -33.10%
$387.8m +11.93%
Cash flows from investing activities:
Capital Expenditure ($190.4m) ($229.2m) ($222.2m) ($229.2m) ($235.8m)
Payments to Acquire Businesses, Net of Cash Acquired $472.2m $27.4m $523.1m $93.7m $20.8m $81.9m $27.0m $29.6m $13.1m $9.2m ($7.1m)
Net Other Investing Changes $8.3m $163k $4.3m $23.4m $25.6m
Net Cash Provided by (Used in) Investing Activities ($554.3m) ($193.0m) ($697.1m) ($316.7m) ($115.4m) ($256.6m) ($226.3m) ($268.5m) ($231.0m) ($216.5m) ($220.8m)
Cash flows from financing activities:
Gain (Loss) on Extinguishment of Debt ($11.6m) ($19.7m) ($14.2m) ($38.1m) $0 $0 $0 ($14.7m) ($28.8m) $0
Issuance Of Debt $1.1b $3.0b $4.3b $1.4b $1.2b
Long Term Debt Issuance $1.1b $3.0b $4.3b $1.4b $1.2b
Long Term Debt Payments ($870.6m) ($3.2b) ($4.8b) ($1.3b) ($1.2b)
Net Issuance Payments Of Debt $264.7m ($204.0m) ($493.5m) $42.3m $1.3m
Net Long Term Debt Issuance $275.1m ($202.3m) ($489.0m) $51.4m $2.6m
Net Short Term Debt Issuance ($10.4m) ($1.7m) ($4.5m) ($9.1m) ($1.3m)
Repayment Of Debt ($881.0m) ($3.2b) ($4.8b) ($1.3b) ($1.2b)
Short Term Debt Issuance $42.4m $1.1b
Short Term Debt Payments ($10.4m) ($1.7m) ($4.5m) ($9.1m) ($7.1m)
Payments of Ordinary Dividends, Common Stock $0 $50.6m $64.6m $63.9m $64.6m $31.4m ($31.1m)
Common Stock Dividend Paid ($64.6m) ($63.9m) ($64.6m) ($31.4m) ($31.1m)
Common Stock Issuance $0 $0 $511.2m $0 $0
Common Stock Payments ($195.5m) ($12.8m) ($37.9m) ($100.1m) ($88.7m)
Issuance Of Capital Stock $0 $0 $511.2m $0 $0
Net Common Stock Issuance ($195.5m) ($12.8m) $473.3m ($100.1m) ($88.7m)
Repurchase Of Capital Stock ($195.5m) ($12.8m) ($37.9m) ($100.1m) ($88.7m)
Cash Dividends Paid ($64.6m) ($63.9m) ($64.6m) ($31.4m) ($31.1m)
Dividend Received CFO $21.9m $23.4m $39.2m $53.0m $46.9m
Net Other Financing Charges ($39.5m) ($46.9m) ($226.4m) ($74.0m) ($76.0m)
Net Cash Provided by (Used in) Financing Activities $292.3m
($21.6m) -107.41%
$255.6m +1280.69%
$32.3m -87.38%
($671.5m) -2182.23%
($647.4m) +3.60%
($34.9m) +94.61%
($327.5m) -838.61%
($311.2m) +4.98%
($163.2m) +47.57%
($194.5m) -19.21%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $23.5m $52.6m $160.7m $241.2m ($502.8m) $23.6m ($13.9m) ($24.3m) ($33.2m) $25.7m
Beginning Cash Position $74.3m $97.9m $84.0m $59.7m $53.2m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $335.9m $577.1m $74.3m $97.9m $84.0m $59.7m $26.5m $25.7m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Proceeds from Stock Options Exercised $1.7m $2.0m $1.7m $964k $0 $0
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $142.6m $149.2m $193.4m $183.0m $155.2m $132.2m $183.5m $272.3m $256.2m $120.6m
Income Taxes Paid, Net $70.8m $65.0m $48.2m $70.6m $108.9m $181.2m $32.3m $88.5m $133.2m $26.0m
Additional Financial Items
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal $35.6m $8.6m $6.5m $12.4m $2.2m $0 $0 ($1.1m) $8k
Gain (Loss) on Disposition of Assets ($2.7m) ($57k) $1.1m ($8k)
Gain (Loss) on Disposition of Business $6.3m $22.6m $2.4m $2.7m $57k
General and Administrative Expense $106.9m $114.0m $121.3m $128.5m $138.0m $147.0m $153.0m $170.2m $225.9m $154.4m
Goodwill $2.8b $2.8b $3.3b $3.4b $3.4b $3.4b $3.5b $3.5b $2.3b $2.4b
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $65.5m $146.2m
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $130.0m $214.5m
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $166.7m $0
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent $148.6m $0
Income Tax Expense (Benefit) $55.5m ($18.2m) $58.6m $63.7m $111.9m $129.8m $62.6m $82.6m $44.8m $58.2m
Interest Expense Nonoperating $128.6m $117.9m
Proceeds from Noncontrolling Interests $11.8m $10.0m $2.9m $18.4m $7.6m $20.7m $9.5m $22.9m $15.7m $15.9m
Proceeds from (Payments to) Noncontrolling Interests $11.8m $10.0m $2.9m $18.4m $7.6m $20.7m $9.5m $22.9m $15.7m $15.9m
Cash Flow From Continuing Financing Activities ($34.9m) ($327.5m) ($311.2m) ($163.2m) ($194.5m)
Cash Flow From Continuing Investing Activities ($226.3m) ($268.5m) ($231.0m) ($216.5m) ($220.8m)
Change In Account Payable ($48.0m) ($6.4m) ($16.8m) ($854k) $6.9m
Change In Cash Supplemental As Reported $23.6m ($13.9m) ($24.3m) ($33.2m)
Change In Other Working Capital ($323.7m) ($83.8m)
Change In Payable ($48.0m) ($6.4m) ($16.8m) ($854k) $6.9m
Changes In Cash $23.6m ($13.9m) ($24.3m) ($33.2m) ($27.5m)
End Cash Position $97.9m $84.0m $59.7m $26.5m $25.7m
Financing Cash Flow ($34.9m)
($327.5m) -838.61%
($311.2m) +4.98%
($163.2m) +47.57%
($194.5m) -19.21%
Free Cash Flow $94.5m $352.9m $295.7m $117.2m $152.0m
Investing Cash Flow ($226.3m) ($268.5m) ($231.0m) ($216.5m) ($220.8m)
Net Business Purchase And Sale ($44.3m) ($39.4m) ($13.1m) ($10.7m) ($10.6m)
Net PPE Purchase And Sale ($190.4m) ($229.2m) ($222.2m) ($229.2m) ($235.8m)
Operating Gains Losses ($29.1m) ($40.7m) ($42.3m) ($54.5m) ($53.9m)
Other Non Cash Items $2.3m $2.6m $3.0m $3.1m
Provisionand Write Offof Assets $174k $1.0m $4.3m $2.4m $1.2m
Purchase Of Business ($44.3m) ($39.4m) ($13.1m) ($10.7m) ($7.1m)
Purchase Of PPE $161.6m $233.2m $167.3m $157.1m $146.4m $180.5m ($190.4m) ($229.2m) ($222.2m) ($229.2m) ($235.8m)
Stock Based Compensation $37.8m $43.8m $100.7m $16.7m $17.4m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.